UPDATE: Accomplishments of a Foundation Scholar – Graham Cochrane
| AbbVie, Inc Research Scholars | |||
|---|---|---|---|
| Scholar | Research Institution | Research Project | MS Research Mentor |
| Nicholas Moll | McGovern Medical School at UTHealth | Automatic Detection and Segmentation of MS Lesions using Multimodal MR Images and Deep Convolutional Neural Networks | Dr. Leorah Freeman |
| Youkyung Sophie Roh | Johns Hopkins University School of Medicine | Depression and MS course: an evaluation of potential mediating effects of commonly used treatments for depression and MS therapies | Dr. Ellen Mowryn |
| Zachary Zapatero | Children’s Hospital of Philadelphia | Evaluating Thalamic Pathology in Pediatric MS | Dr. Brenda Banwell |
| Melissa Zhou | Yale School of Medicine | Outcomes following a first clinical event in children with the radiologically isolated syndrome | Dr. Naila Makhani |
| Bayer HealthCare/June Halper Research Scholar | |||
| Scholar | Research Institution | Research Project | MS Research Mentor |
| Kimberly Young | SickKids Research Institute | Visual and MRI Outcomes in Pediatric Multiple Sclerosis | Dr. E. Ann Yeh |
| Inserra Family Research Scholar | |||
| Scholar | Research Institution | Research Project | MS Research Mentor |
| Sonya Steele | National Institutes of Neurological Disorders and Stroke | MRI and Clinical Findings in Health, Genetically Characterized Asymptomatic First-Degree Relatives of MS Patients and Health Controls | Dr. Daniel Reich |
| Sanofi Genzyme Research Scholars | |||
| Scholar | Research Institution | Research Project | MS Research Mentor |
| Graham Cochrane | University of Alabama at Birmingham | Relationship between Fatigue and Vestibular Function in Persons with MS | Dr. Robert Motl |
| Lauren Hall | UMASS Medical School | MS and the Microbiota | Dr. Carolina Ionete |
| Noble Jones | Mellen Center/Cleveland Clinic Foundation | Predictors of Intrathecal Baclofen Therapy Outcomes in Multiple Sclerosis Patients | Dr. Francois Bethoux |
| Samuel Marcucci | University of Cincinnati & The Waddell Center for Multiple Sclerosis | The Effect of Ocrelizumab on Lymphocytes in MS Previously Exposed to Lymphocyte Depleting Agents | Dr. Aram Zabeti & Dr. Ahmed Obeidat |